Reference Listed Drugs (RLDs) for ANDA & Bioequivalence Studies

Sourced with Batch-Level Traceability

SRA-origin comparator sourcing aligned with development timelines, regulatory expectations, and study-critical handling requirements.

United States (FDA) United Kingdom (MHRA) European Union (EMA) Canada (Health Canada) Australia (TGA) Japan (PMDA)

GDP-Aligned Handling Standards

Handling aligned with labeled storage conditions.

Temperature-Controlled Logistics

Cold chain logistics with continuous monitoring.

Batch & Expiry Traceability

Batch and expiry visibility with complete documentation every shipment.

Global Sourcing Network

Access to all major SRA markets worldwide.

Supporting Comparator Sourcing in Development Programs

  • Identification of RLD aligned with target submission market
  • Batch selection based on availability and study suitability
  • Expiry window considerations for BE and stability timelines
  • Sourcing aligned with regulatory and documentation expectations

Everything you need.
Comparator procurement from one source.

  • Origin-market sourcing from FDA, EMA, MHRA, Health Canada, TGA and PMDA regions
  • Multiple batch and expiry options
  • Cold-chain and ambient logistics with monitoring
  • Support for hard-to-source and short-dated RLDs
  • Documentation aligned with regulatory and BE study requirements
  • Dedicated account management for pharma and CRO clients

You're not optimizing for price. You're eliminating risk.

Every RLD purchase carries critical authenticity, timeline, and regulatory risk. We eliminate all three.

Proven Authenticity

GDP-certified chain of custody

Chain-of-custody style traceability from SRA-origin countries to your facility.

Financial Risk

$500 to $10,000 per product

Counterfeit equals total loss. GDP certification protects your investment.

Timeline Risk

Delays kill market entry

Regulatory Risk

Wrong origin rejects dossiers

Global Operations

Dubai Free Zone

Built by someone who's been the customer.

After 20 years running a pharmaceutical manufacturing company and facing unreliable suppliers, we built Imperial Co. to solve those same sourcing problems ourselves.

We source only from SRA-origin countries, maintain GDP-aligned standards, and run each shipment with documented traceability.

50+ Clients
Clients Served
7 of Top 10
Industry Leaders
32 Days
Average Delivery

Trusted by pharmaceutical leaders.
Delivering results that matter.

50+
Clients served across the region
7/10
of top leaders trust us
32
days average delivery time

Supporting pharmaceutical R&D across all applications.

Bioequivalence ANDA Studies

SRA-origin RLDs required for regulatory submissions and BE testing.

Clinical Trial Comparator Supply

Reliable comparator drugs for trial programs with complete documentation.

Analytical Reference Products

Reference standards for analytical and bioanalytical laboratory testing.

Strict quality, traceability, and temperature-control standards.

Handling aligned with labeled storage. Traceability from source to delivery. Batch and expiry visibility with every shipment.

Documented sourcing channels; SRA-origin reference products
Handling aligned with storage conditions; validated pack-outs
Shipment temperature monitoring and complete documentation

Need a comparator or RLD urgently?

Upload your list and target market, and we'll confirm availability and timelines.